XT
IMPL

XTX Topco’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

XTX Topco’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,222
Closed -$9.13K – 2298
2023
Q3 		$9.13K Buy
+21,222
New +$20.4K ﹤0.01% 1427

Other funds holding IMPL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

XTX Topco's IMPL Position: Q4 2023 in Review

XTX Topco sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 21,222 shares — an estimated $9.13K sold.

XTX Topco first reported a position in IMPL in Q3 2023 and held it in 1 quarter. The position peaked at $9.13K in Q3 2023. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

  • XTX Topco reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • XTX Topco sold 21,222 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $9.13K.
  • XTX Topco first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • XTX Topco's Impel Pharmaceuticals Inc. Common Stock position peaked at $9.13K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.